ENSG Stock Analysis — The Ensign Group
Sector: Healthcare
AI Verdict
Ensign trades at 20.1x next year's earnings for nearly 40% expected EPS growth — that's cheap for the growth you're getting if the local-operator moat keeps driving outperformance.
Competitive Moat
Ensign operates skilled nursing and senior living facilities with a decentralized cluster model, allowing local operators to tailor care and maximize occupancy. This operational autonomy creates a moat by driving higher efficiency and local market share, making it harder for large chains to compete on both cost and quality.
Summary
A 39.8% expected EPS jump and a forward P/E of 20.1x put Ensign at the intersection of rapid earnings growth and a valuation reset.
Where It Stands
Shares trade at 20.1x next year's earnings, below the healthcare sector median of 22x, while analysts expect 39.8% EPS growth — a rare combination of growth and a below-average multiple.
Key Metrics
- Trailing P/E: 28.2x
- Forward P/E: 20.1x
- PEG Ratio: 0.71
- Earnings Growth: +0.4%
- Revenue Growth: +0.2%
- Dividend Yield: 0.00%
- 52-Week High: $218.00
- 52-Week Low: $134.79
Analyst Consensus
9 Buy · 2 Hold · 0 Sell (11 analysts)
Bull Case
With forward EPS expected to rise 39.8% and a forward P/E of 20.1x, you're getting growth at a price that undercuts the sector median.
Bear Case
If the forward P/E reverts to the sector median of 22x without the full 39.8% EPS growth materializing, the stock could see a multiple compression that erases much of the upside.
Catalyst to Watch
Quarterly earnings beats or misses will directly test whether the 39.8% EPS growth forecast is realistic.